Parkinson's disease is often treated as a single disorder. But for the more than 1.1 million people living with it in the United States, the disease can look different from one person to the next.
Researchers develop a non-toxic Parkinson's disease model using the TMEV virus, proving viral infections can trigger dopamine neuron loss and gait issues.
University of California, San Francisco (UCSF) scientists have developed a form of neurological pacemaker that adapts in real ...
A newly identified protein called GPNMB may play a major role in helping Parkinson’s disease spread through the brain. Researchers discovered that immune cells release the protein in response to ...
As the global population ages, the prevalence of Parkinson’s continues to rise, with an estimated 25 million people expected to be living with the neurological disease by 2050. The incurable ...
A virus long thought to be harmless may actually play a role in Parkinson’s disease, a condition that affects more than one million Americans. Northwestern Medicine scientists discovered Human ...
Somewhere in the tangle of a brain under siege by Parkinson’s disease, immune cells appear to be doing something remarkable: building microscopic rescue tunnels to dying neurons, sucking out toxic ...
Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new treatment for one type of Parkinson's disease may be on the ...
Keith Krehbiel has broken more ribs than he can count — from bike crashes to falls during pickleball matches. Another time, he climbed up the stairwell in his home and blacked out just as he reached ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results